Evidence map›Paper›PMID 19918975›Full record

ArticleHepatology (Baltimore, Md.)2010

Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection.

Michael J Fuller, Naglaa H Shoukry, Toshifumi Gushima, David G Bowen, Benoit Callendret, Katherine J Campbell, Dana L Hasselschwert, Austin L Hughes, Christopher M Walker

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Hepatology (Baltimore, Md.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Current Trends in Neoantigen-Based Cancer Vaccines.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  3. Review
  4. Review
  5. Review
  6. Adaptive Immune Response against Hepatitis C Virus.International journal of molecular sciences · 2020
    Review
  7. Review
  8. Review
  9. Evidence of CD4Scientific reports · 2018
    Article
  10. Article
  11. Association ofEXCLI journal · 2018
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Michael J FullerCenter for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.
Naglaa H Shoukry
Toshifumi Gushima
David G Bowen
Benoit Callendret
Katherine J Campbell
Dana L Hasselschwert
Austin L Hughes
Christopher M Walker
Nationwide Children's Hospital · USThe Ohio State University · USUniversity of Louisiana at Lafayette · USUniversity of South Carolina · US

Funding

EXPANSION OF NIH CHIMPANZEE HOLDING FACC06RR016483 · NCRR · UNIVERSITY OF LOUISIANA AT LAFAYETTE · PI ROWELL, THOMAS J. · 2002 to 2002
$2.0M
POLYMORPHISM &EVOLUTION OF MHC GENESR01GM043940 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HUGHES, AUSTIN L. · 1990 to 2010
$1.5M
NCRR NIH HHS C06 RR016483NIGMS NIH HHS R01 GM043940
6 · The paper itself

Abstract

unlabelledImmune escape driven by selection pressure from virus-specific CD8 T cells has been demonstrated in both chimpanzees and humans infected with the hepatitis C virus (HCV). Although escape mutations have also been characterized in major histocompatibility complex (MHC) class II-restricted HCV epitopes, it is unknown whether selection-driven immune escape by CD4 T cell epitopes is a significant factor in the failure of these responses or contributes to persistent infection. To address this issue, evolution of MHC class I- and class II-restricted HCV epitopes was compared in four chimpanzees persistently infected with the virus for more than 10 years. We identified an amino acid change in a CD4 epitope of the HCV NS3 protein in one of the chimpanzees 3 years after infection. This mutation resulted in diminished activation, cytokine production (interferon-gamma and interleukin-2), and proliferation by an epitope-specific CD4 T cell line. We expanded our analysis to determine if mutations were common in multiple CD4 versus CD8 T cell epitopes in the four chronically infected animals. Whereas we observed mutations in over 75% of CD8 T cell epitopes analyzed in this study, only 18% of CD4 T cell epitopes analyzed showed amino acid changes. The frequency of changes in class II epitopes was not different from flanking regions, so CD4 T cells rarely exert selection pressure against the HCV genome.

conclusionApparent mutational escape can occur in MHC class II-restricted epitopes, but this is uncommon when compared with class I-restricted epitopes in the same individual. This indicates that other mechanisms for silencing CD4 T cells are dominant in persistent HCV infections.

Indexed as

Immune EvasionAnimalsCD4-Positive T-LymphocytesEpitopesGenes, MHC Class IIHepacivirusHepatitis CMutationPan troglodytesEpitopes

Identifiers

PMID19918975
PMCPMC2821874
OpenAlexW2012180137

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.